Rankings
▼
Calendar
LXRX Q1 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$27,000
-99.7% YoY
Gross Profit
-$13M
-46600.0% margin
Operating Income
-$21M
-77181.5% margin
Net Income
-$21M
-77622.2% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
-86.4%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$193M
Total Liabilities
$41M
Stockholders' Equity
$153M
Cash & Equivalents
$98M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$27,000
$8M
-99.7%
Gross Profit
-$13M
$7M
-269.3%
Operating Income
-$21M
-$62M
+66.6%
Net Income
-$21M
-$67M
+68.5%
← FY 2021
All Quarters
Q2 2021 →